Reunion Neuroscience Inc. announced that it has appointed Edward Smith as the Company's Chief Financial Officer Mr. Smith will report to Greg Mayes, Reunion's President and CEO Edward Smith is an industry veteran with more than 20 years of financial management experience and has served as CFO of several publicly traded, clinical-stage biotechnology companies where has successfully raised over $600 million from institutional investors. Prior to joining Reunion, Mr. Smith was CFO and took public LAVA Therapeutics N.V., Marinus Pharmaceuticals Inc. and PolyMedix Inc. and prior to that, he was executive director of finance at InKine Pharmaceutical Company Inc., where he assisted with the acquisition of that company by Salix Pharmaceuticals Inc. Earlier in his career, he held various positions of increasing responsibility in public accounting, most recently in the audit practice at Deloitte & Touche, LLP. Mr. Smith is currently a member of the board of directors at Benitec Biopharma Inc. He holds a B.S. in business administration from the University of Hartford and was licensed as a Certified Public Accountant in Pennsylvania.

Edward Smith succeeds Donna Wong who has resigned as Chief Financial Officer.